首页 | 本学科首页   官方微博 | 高级检索  
     


Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
Authors:Ioannis Koulouridis  Mansour Alfayez  Thomas A. Trikalinos  Ethan M. Balk  Bertrand L. Jaber
Affiliation:1 Department of Medicine, Division of Nephrology, Kidney and Dialysis Research Laboratory, St. Elizabeth''s Medical Center, Boston, MA;2 Department of Medicine, Tufts University School of Medicine, Tufts University, Boston, MA;3 Center for Clinical Evidence Synthesis, Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA;4 Center for Evidence-based Medicine, Brown University, Providence, RI
Abstract:
Keywords:Erythropoietin   erythropoiesis-stimulating agent (ESA)   epoetin   darbepoetin   anemia   chronic kidney disease (CKD)   dose   mortality   cardiovascular morbidity   metaregression
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号